The global market for Angiogenesis Assay was estimated to be worth US$ 18 million in 2023 and is forecast to a readjusted size of US$ 31 million by 2030 with a CAGR of 7.8% during the forecast period 2024-2030.

Angiogenesis Assay Market

Angiogenesis is the tightly regulated process by which new blood vessels are formed from the existing vasculature. This process is physiologically important for development and wound healing, and is also a common driver in multiple diseases including rheumatoid arthritis, atherosclerosis, macular degeneration, and cancer. Angiogenesis occurs in response to a variety of molecular cues. Generally, the angiogenic process includes endothelial cell proliferation, chemotactic endothelial cell migration through the extracellular matrix barrier, and the formation of capillary tubes. Physiological and pathological angiogenesis utilize many of the same cellular processes and molecular signaling networks, however the structures that form during pathological angiogenesis are often functionally abnormal.

Global Angiogenesis Assay key players include Abcam, Bio-Techne, Thermo Fisher Scientific, PromoCell GmbH, Merck KGaA, etc. Global top five manufacturers hold a share over 65%.

North America is the largest market, with a share over 35%, followed by Europe and Asia Pacific, both have a share nearly 60 percent. In terms of product, In Vitro Assay Kit is the largest segment, with a share over 95%. And in terms of application, the largest application is Academic Institution, followed by Biotech Companies, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Angiogenesis Assay, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Angiogenesis Assay.

The Angiogenesis Assay market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Angiogenesis Assay market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Angiogenesis Assay companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Market Segmentation

Scope of Angiogenesis Assay Market Report

Report Metric	Details
Report Name	Angiogenesis Assay Market
Forecasted market size in 2030	US$ 31 million
CAGR	7.8%
Forecasted years	2024 - 2030
Segment by Type	In Vitro Assay Kit In Vivo Assay Kit
Segment by Application	Academic Institution Biotech Companies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abcam, Bio-Techne, Thermo Fisher Scientific, Cell Biolabs, Inc., BioVision, Inc, PromoCell GmbH, Merck KGaA, Kollodis BioSciences, Sartorius (Essen BioScience), Creative Bioarray
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Angiogenesis Assay in global and regional level.
Chapter 3: Detailed analysis of Angiogenesis Assay company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Angiogenesis Assay revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Angiogenesis Assay Market size in 2030?

Ans: The Angiogenesis Assay Market size in 2030 will be US$ 31 million.

What is the market share of major companies in Angiogenesis Assay Market?

Ans: Global top five manufacturers hold a share over 65%.

What is the Angiogenesis Assay Market share by type?

Ans: In terms of product, In Vitro Assay Kit is the largest segment, with a share over 95%.

Who are the main players in the Angiogenesis Assay Market report?

Ans: The main players in the Angiogenesis Assay Market are Abcam, Bio-Techne, Thermo Fisher Scientific, Cell Biolabs, Inc., BioVision, Inc, PromoCell GmbH, Merck KGaA, Kollodis BioSciences, Sartorius (Essen BioScience), Creative Bioarray

What are the Application segmentation covered in the Angiogenesis Assay Market report?

Ans: The Applications covered in the Angiogenesis Assay Market report are Academic Institution, Biotech Companies

What are the Type segmentation covered in the Angiogenesis Assay Market report?

Ans: The Types covered in the Angiogenesis Assay Market report are In Vitro Assay Kit, In Vivo Assay Kit

1 Study Coverage

1.1 Angiogenesis Assay Product Introduction

1.2 Market by Type

1.2.1 Global Angiogenesis Assay Market Size Growth Rate by Type (2019 VS 2023 VS 2030)

1.2.2 In Vitro Assay Kit

1.2.3 In Vivo Assay Kit

1.3 Market by Application

1.3.1 Global Angiogenesis Assay Market Size Growth Rate by Application (2019 VS 2023 VS 2030)

1.3.2 Academic Institution

1.3.3 Biotech Companies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Angiogenesis Assay Market Size Estimates and Forecasts

2.2 Angiogenesis Assay Market Size by Region: 2023 Versus 2030

2.2.1 Global Angiogenesis Assay Revenue by Region: 2019-2024

2.2.2 Global Angiogenesis Assay Revenue Forecast by Region (2025-2030)

2.2.3 Global Angiogenesis Assay Revenue Market Share by Region (2019-2030)

3 Global Angiogenesis Assay by Company

3.1 Global Angiogenesis Assay Revenue by Company (2019-2024)

3.2 Global Angiogenesis Assay Revenue Share by Company (2019-2024)

3.3 Competitive Landscape

3.3.1 Key Angiogenesis Assay Companies around the World: Ranking by Revenue

3.3.2 Global Angiogenesis Assay Market Concentration Ratio (CR5 and HHI) & (2019-2024)

3.3.3 Global Angiogenesis Assay Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.4 Global Angiogenesis Assay Companies Headquarters & Product Type

3.4.1 Angiogenesis Assay Companies Headquarters

3.4.2 Global Angiogenesis Assay Companies Product & Service

3.4.3 Date of International Companies Enter into Angiogenesis Assay Market

3.5 Global Angiogenesis Assay Mergers & Acquisitions, Expansion Plans

4 Company Profiles

4.1 Abcam

4.1.1 Abcam Company Information

4.1.2 Abcam Description, Business Overview

4.1.3 Abcam Angiogenesis Assay Products Offered

4.1.4 Abcam Angiogenesis Assay Revenue and Gross Margin (2019-2024)

4.1.5 Abcam Angiogenesis Assay Revenue by Product in 2023

4.1.6 Abcam Angiogenesis Assay Revenue by Application in 2023

4.1.7 Abcam Angiogenesis Assay Revenue by Geographic Area in 2023

4.1.8 Abcam Recent Developments

4.2 Bio-Techne

4.2.1 Bio-Techne Company Information

4.2.2 Bio-Techne Description, Business Overview

4.2.3 Bio-Techne Angiogenesis Assay Products Offered

4.2.4 Bio-Techne Angiogenesis Assay Revenue and Gross Margin (2019-2024)

4.2.5 Bio-Techne Angiogenesis Assay Revenue by Product in 2023

4.2.6 Bio-Techne Angiogenesis Assay Revenue by Application in 2023

4.2.7 Bio-Techne Angiogenesis Assay Revenue by Geographic Area in 2023

4.2.8 Bio-Techne Recent Developments

4.3 Thermo Fisher Scientific

4.3.1 Thermo Fisher Scientific Company Information

4.3.2 Thermo Fisher Scientific Description, Business Overview

4.3.3 Thermo Fisher Scientific Angiogenesis Assay Products Offered

4.3.4 Thermo Fisher Scientific Angiogenesis Assay Revenue and Gross Margin (2019-2024)

4.3.5 Thermo Fisher Scientific Angiogenesis Assay Revenue by Product in 2023

4.3.6 Thermo Fisher Scientific Angiogenesis Assay Revenue by Application in 2023

4.3.7 Thermo Fisher Scientific Angiogenesis Assay Revenue by Geographic Area in 2023

4.3.8 Thermo Fisher Scientific Recent Developments

4.4 Cell Biolabs, Inc.

4.4.1 Cell Biolabs, Inc. Company Information

4.4.2 Cell Biolabs, Inc. Description, Business Overview

4.4.3 Cell Biolabs, Inc. Angiogenesis Assay Products Offered

4.4.4 Cell Biolabs, Inc. Angiogenesis Assay Revenue and Gross Margin (2019-2024)

4.4.5 Cell Biolabs, Inc. Angiogenesis Assay Revenue by Product in 2023

4.4.6 Cell Biolabs, Inc. Angiogenesis Assay Revenue by Application in 2023

4.4.7 Cell Biolabs, Inc. Angiogenesis Assay Revenue by Geographic Area in 2023

4.4.8 Cell Biolabs, Inc. Recent Developments

4.5 BioVision, Inc

4.5.1 BioVision, Inc Company Information

4.5.2 BioVision, Inc Description, Business Overview

4.5.3 BioVision, Inc Angiogenesis Assay Products Offered

4.5.4 BioVision, Inc Angiogenesis Assay Revenue and Gross Margin (2019-2024)

4.5.5 BioVision, Inc Angiogenesis Assay Revenue by Product in 2023

4.5.6 BioVision, Inc Angiogenesis Assay Revenue by Application in 2023

4.5.7 BioVision, Inc Angiogenesis Assay Revenue by Geographic Area in 2023

4.5.8 BioVision, Inc Recent Developments

4.6 PromoCell GmbH

4.6.1 PromoCell GmbH Company Information

4.6.2 PromoCell GmbH Description, Business Overview

4.6.3 PromoCell GmbH Angiogenesis Assay Products Offered

4.6.4 PromoCell GmbH Angiogenesis Assay Revenue and Gross Margin (2019-2024)

4.6.5 PromoCell GmbH Angiogenesis Assay Revenue by Product in 2023

4.6.6 PromoCell GmbH Angiogenesis Assay Revenue by Application in 2023

4.6.7 PromoCell GmbH Angiogenesis Assay Revenue by Geographic Area in 2023

4.6.8 PromoCell GmbH Recent Development

4.7 Merck KGaA

4.7.1 Merck KGaA Company Information

4.7.2 Merck KGaA Description, Business Overview

4.7.3 Merck KGaA Angiogenesis Assay Products Offered

4.7.4 Merck KGaA Angiogenesis Assay Revenue and Gross Margin (2019-2024)

4.7.5 Merck KGaA Angiogenesis Assay Revenue by Product in 2023

4.7.6 Merck KGaA Angiogenesis Assay Revenue by Application in 2023

4.7.7 Merck KGaA Angiogenesis Assay Revenue by Geographic Area in 2023

4.7.8 Merck KGaA Recent Development

4.8 Kollodis BioSciences

4.8.1 Kollodis BioSciences Company Information

4.8.2 Kollodis BioSciences Description, Business Overview

4.8.3 Kollodis BioSciences Angiogenesis Assay Products Offered

4.8.4 Kollodis BioSciences Angiogenesis Assay Revenue and Gross Margin (2019-2024)

4.8.5 Kollodis BioSciences Angiogenesis Assay Revenue by Product in 2023

4.8.6 Kollodis BioSciences Angiogenesis Assay Revenue by Application in 2023

4.8.7 Kollodis BioSciences Angiogenesis Assay Revenue by Geographic Area in 2023

4.8.8 Kollodis BioSciences Recent Development

4.9 Sartorius (Essen BioScience)

4.9.1 Sartorius (Essen BioScience) Company Information

4.9.2 Sartorius (Essen BioScience) Description, Business Overview

4.9.3 Sartorius (Essen BioScience) Angiogenesis Assay Products Offered

4.9.4 Sartorius (Essen BioScience) Angiogenesis Assay Revenue and Gross Margin (2019-2024)

4.9.5 Sartorius (Essen BioScience) Angiogenesis Assay Revenue by Product in 2023

4.9.6 Sartorius (Essen BioScience) Angiogenesis Assay Revenue by Application in 2023

4.9.7 Sartorius (Essen BioScience) Angiogenesis Assay Revenue by Geographic Area in 2023

4.9.8 Sartorius (Essen BioScience) Recent Development

4.10 Creative Bioarray

4.10.1 Creative Bioarray Company Information

4.10.2 Creative Bioarray Description, Business Overview

4.10.3 Creative Bioarray Angiogenesis Assay Products Offered

4.10.4 Creative Bioarray Angiogenesis Assay Revenue and Gross Margin (2019-2024)

4.10.5 Creative Bioarray Angiogenesis Assay Revenue by Product in 2023

4.10.6 Creative Bioarray Angiogenesis Assay Revenue by Application in 2023

4.10.7 Creative Bioarray Angiogenesis Assay Revenue by Geographic Area in 2023

4.10.8 Creative Bioarray Recent Development

5 Breakdown Data by Type

5.1 Global Angiogenesis Assay Revenue by Type (2019-2024)

5.2 Global Angiogenesis Assay Revenue Forecast by Type (2025-2030)

5.3 Angiogenesis Assay Revenue Market Share by Type (2019-2030)

6 Breakdown Data by Application

6.1 Global Angiogenesis Assay Revenue by Application (2019-2024)

6.2 Global Angiogenesis Assay Revenue Forecast by Application (2025-2030)

6.3 Angiogenesis Assay Revenue Market Share by Application (2019-2030)

7 North America

7.1 North America Angiogenesis Assay Market Size YoY Growth 2019-2030

7.2 North America Angiogenesis Assay Market Facts & Figures by Country (2019-2030)

7.3 North America Angiogenesis Assay Revenue by Type (2019-2024)

7.4 North America Angiogenesis Assay Revenue by Application (2019-2024)

8 Asia-Pacific

8.1 Asia-Pacific Angiogenesis Assay Market Size YoY Growth 2019-2030

8.2 Asia-Pacific Angiogenesis Assay Market Facts & Figures by Region (2019-2030)

8.3 Asia-Pacific Angiogenesis Assay Revenue by Type (2019-2024)

8.4 Asia-Pacific Angiogenesis Assay Revenue by Application (2019-2024)

9 Europe

9.1 Europe Angiogenesis Assay Market Size YoY Growth 2019-2030

9.2 Europe Angiogenesis Assay Market Facts & Figures by Country (2019-2030)

9.3 Europe Angiogenesis Assay Revenue by Type (2019-2024)

9.4 Europe Angiogenesis Assay Revenue by Application (2019-2024)

10 Latin America

10.1 Latin America Angiogenesis Assay Market Size YoY Growth 2019-2030

10.2 Latin America Angiogenesis Assay Market Facts & Figures by Country (2019-2030)

10.3 Latin America Angiogenesis Assay Revenue by Type (2019-2024)

10.4 Latin America Angiogenesis Assay Revenue by Application (2019-2024)

11 Middle East and Africa

11.1 Middle East and Africa Angiogenesis Assay Market Size YoY Growth 2019-2030

11.2 Middle East and Africa Angiogenesis Assay Market Facts & Figures by Country (2019-2030)

11.3 Middle East and Africa Angiogenesis Assay Revenue by Type (2019-2024)

11.4 Middle East and Africa Angiogenesis Assay Revenue by Application (2019-2024)

12 Supply Chain and Sales Channel Analysis

12.1 Angiogenesis Assay Supply Chain Analysis

12.2 Angiogenesis Assay Key Raw Materials and Upstream Suppliers

12.3 Angiogenesis Assay Clients Analysis

12.4 Angiogenesis Assay Sales Channel and Sales Model Analysis

12.4.1 Angiogenesis Assay Distribution Channel Analysis: Indirect Sales VS Direct Sales

12.4.2 Angiogenesis Assay Distribution Channel Analysis: Online Sales VS Offline Sales

12.4.3 Angiogenesis Assay Distributors

13 Market Dynamics

13.1 Angiogenesis Assay Industry Trends

13.2 Angiogenesis Assay Market Drivers

13.3 Angiogenesis Assay Market Challenges

13.4 Angiogenesis Assay Market Restraints

14 Research Findings and Conclusion

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Abcam

Bio-Techne

Thermo Fisher Scientific

Sartorius (Essen BioScience)

Creative Bioarray

List of Tables

Table 1. Global Angiogenesis Assay Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Major Companies of In Vitro Assay Kit

Table 3. Major Companies of In Vivo Assay Kit

Table 4. Global Angiogenesis Assay Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Angiogenesis Assay Market Size by Region (US$ Million): 2023 VS 2030

Table 6. Global Angiogenesis Assay Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Angiogenesis Assay Revenue Forecast by Region (2025-2030) & (US$ Million)

Table 8. Angiogenesis Assay Revenue by Company (2019-2024) & (US$ Million)

Table 9. Angiogenesis Assay Revenue Share by Company (2019-2024)

Table 10. Ranking of Global Top Angiogenesis Assay Players by Revenue (US$ Million) in 2023

Table 11. Global Angiogenesis Assay Companies Market Concentration Ratio (CR5 and HHI) & (2019-2024)

Table 12. Global Angiogenesis Assay by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Angiogenesis Assay as of 2023)

Table 13. Global Angiogenesis Assay Companies Headquarters

Table 14. Global Angiogenesis Assay Companies Product & Service

Table 15. Date of International Companies Enter into Angiogenesis Assay Market

Table 16. Global Angiogenesis Assay Mergers & Acquisitions, Expansion Plans

Table 17. Abcam Company Information

Table 18. Abcam Description and Business Overview

Table 19. Abcam Angiogenesis Assay Product

Table 20. Abcam Angiogenesis Assay Revenue (US$ Million) and Gross Margin (2019-2024)

Table 21. Abcam Revenue Proportion of Angiogenesis Assay by Product in 2023

Table 22. Abcam Revenue Proportion of Angiogenesis Assay by Application in 2023

Table 23. Abcam Revenue Proportion of Angiogenesis Assay by Geographic Area in 2023

Table 24. Abcam Recent Development

Table 25. Bio-Techne Company Information

Table 26. Bio-Techne Description and Business Overview

Table 27. Bio-Techne Angiogenesis Assay Product

Table 28. Bio-Techne Angiogenesis Assay Revenue (US$ Million) and Gross Margin (2019-2024)

Table 29. Bio-Techne Revenue Proportion of Angiogenesis Assay by Product in 2023

Table 30. Bio-Techne Revenue Proportion of Angiogenesis Assay by Application in 2023

Table 31. Bio-Techne Revenue Proportion of Angiogenesis Assay by Geographic Area in 2023

Table 32. Bio-Techne Recent Development

Table 33. Thermo Fisher Scientific Company Information

Table 34. Thermo Fisher Scientific Description and Business Overview

Table 35. Thermo Fisher Scientific Angiogenesis Assay Product

Table 36. Thermo Fisher Scientific Angiogenesis Assay Revenue (US$ Million) and Gross Margin (2019-2024)

Table 37. Thermo Fisher Scientific Revenue Proportion of Angiogenesis Assay by Product in 2023

Table 38. Thermo Fisher Scientific Revenue Proportion of Angiogenesis Assay by Application in 2023

Table 39. Thermo Fisher Scientific Revenue Proportion of Angiogenesis Assay by Geographic Area in 2023

Table 40. Thermo Fisher Scientific Recent Development

Table 41. Cell Biolabs, Inc. Company Information

Table 42. Cell Biolabs, Inc. Description and Business Overview

Table 43. Cell Biolabs, Inc. Angiogenesis Assay Product

Table 44. Cell Biolabs, Inc. Angiogenesis Assay Revenue (US$ Million) and Gross Margin (2019-2024)

Table 45. Cell Biolabs, Inc. Revenue Proportion of Angiogenesis Assay by Product in 2023

Table 46. Cell Biolabs, Inc. Revenue Proportion of Angiogenesis Assay by Application in 2023

Table 47. Cell Biolabs, Inc. Revenue Proportion of Angiogenesis Assay by Geographic Area in 2023

Table 48. Cell Biolabs, Inc. Recent Development

Table 49. BioVision, Inc Company Information

Table 50. BioVision, Inc Description and Business Overview

Table 51. BioVision, Inc Angiogenesis Assay Product

Table 52. BioVision, Inc Angiogenesis Assay Revenue (US$ Million) and Gross Margin (2019-2024)

Table 53. BioVision, Inc Revenue Proportion of Angiogenesis Assay by Product in 2023

Table 54. BioVision, Inc Revenue Proportion of Angiogenesis Assay by Application in 2023

Table 55. BioVision, Inc Revenue Proportion of Angiogenesis Assay by Geographic Area in 2023

Table 56. BioVision, Inc Recent Development

Table 57. PromoCell GmbH Company Information

Table 58. PromoCell GmbH Description and Business Overview

Table 59. PromoCell GmbH Angiogenesis Assay Product

Table 60. PromoCell GmbH Angiogenesis Assay Revenue (US$ Million) and Gross Margin (2019-2024)

Table 61. PromoCell GmbH Revenue Proportion of Angiogenesis Assay by Product in 2023

Table 62. PromoCell GmbH Revenue Proportion of Angiogenesis Assay by Application in 2023

Table 63. PromoCell GmbH Revenue Proportion of Angiogenesis Assay by Geographic Area in 2023

Table 64. PromoCell GmbH Recent Development

Table 65. Merck KGaA Company Information

Table 66. Merck KGaA Description and Business Overview

Table 67. Merck KGaA Angiogenesis Assay Product

Table 68. Merck KGaA Angiogenesis Assay Revenue (US$ Million) and Gross Margin (2019-2024)

Table 69. Merck KGaA Revenue Proportion of Angiogenesis Assay by Product in 2023

Table 70. Merck KGaA Revenue Proportion of Angiogenesis Assay by Application in 2023

Table 71. Merck KGaA Revenue Proportion of Angiogenesis Assay by Geographic Area in 2023

Table 72. Merck KGaA Recent Development

Table 73. Kollodis BioSciences Company Information

Table 74. Kollodis BioSciences Description and Business Overview

Table 75. Kollodis BioSciences Angiogenesis Assay Product

Table 76. Kollodis BioSciences Angiogenesis Assay Revenue (US$ Million) and Gross Margin (2019-2024)

Table 77. Kollodis BioSciences Revenue Proportion of Angiogenesis Assay by Product in 2023

Table 78. Kollodis BioSciences Revenue Proportion of Angiogenesis Assay by Application in 2023

Table 79. Kollodis BioSciences Revenue Proportion of Angiogenesis Assay by Geographic Area in 2023

Table 80. Kollodis BioSciences Recent Development

Table 81. Sartorius (Essen BioScience) Company Information

Table 82. Sartorius (Essen BioScience) Description and Business Overview

Table 83. Sartorius (Essen BioScience) Angiogenesis Assay Product

Table 84. Sartorius (Essen BioScience) Angiogenesis Assay Revenue (US$ Million) and Gross Margin (2019-2024)

Table 85. Sartorius (Essen BioScience) Revenue Proportion of Angiogenesis Assay by Product in 2023

Table 86. Sartorius (Essen BioScience) Revenue Proportion of Angiogenesis Assay by Application in 2023

Table 87. Sartorius (Essen BioScience) Revenue Proportion of Angiogenesis Assay by Geographic Area in 2023

Table 88. Sartorius (Essen BioScience) Recent Development

Table 89. Creative Bioarray Company Information

Table 90. Creative Bioarray Description and Business Overview

Table 91. Creative Bioarray Angiogenesis Assay Product

Table 92. Creative Bioarray Angiogenesis Assay Revenue (US$ Million) and Gross Margin (2019-2024)

Table 93. Creative Bioarray Revenue Proportion of Angiogenesis Assay by Product in 2023

Table 94. Creative Bioarray Revenue Proportion of Angiogenesis Assay by Application in 2023

Table 95. Creative Bioarray Revenue Proportion of Angiogenesis Assay by Geographic Area in 2023

Table 96. Creative Bioarray Recent Development

Table 97. Global Angiogenesis Assay Revenue by Type (2019-2024) & (US$ Million)

Table 98. Global Angiogenesis Assay Revenue Forecast by Type (2025-2030) & (US$ Million)

Table 99. Global Angiogenesis Assay Revenue by Application (2019-2024) & (US$ Million)

Table 100. Global Angiogenesis Assay Revenue Forecast by Application (2025-2030) & (US$ Million)

Table 101. North America Angiogenesis Assay Revenue by Country (2019-2024) & (US$ Million)

Table 102. North America Angiogenesis Assay Revenue by Country (2025-2030) & (US$ Million)

Table 103. North America Angiogenesis Assay Revenue by Type (2019-2024) & (US$ Million)

Table 104. North America Angiogenesis Assay Revenue by Application (2019-2024) & (US$ Million)

Table 105. Asia-Pacific Angiogenesis Assay Revenue by Region (2019-2030) & (US$ Million)

Table 106. Asia-Pacific Angiogenesis Assay Revenue by Region (2025-2030) & (US$ Million)

Table 107. Asia-Pacific Angiogenesis Assay Revenue by Type (2019-2024) & (US$ Million)

Table 108. Asia-Pacific Angiogenesis Assay Revenue by Application (2019-2024) & (US$ Million)

Table 109. Europe Angiogenesis Assay Revenue by Country (2019-2024) & (US$ Million)

Table 110. Europe Angiogenesis Assay Revenue by Country (2025-2030) & (US$ Million)

Table 111. Europe Angiogenesis Assay Revenue by Type (2019-2024) & (US$ Million)

Table 112. Europe Angiogenesis Assay Revenue by Application (2019-2024) & (US$ Million)

Table 113. Latin America Angiogenesis Assay Revenue by Country (2019-2024) & (US$ Million)

Table 114. Latin America Angiogenesis Assay Revenue by Country (2025-2030) & (US$ Million)

Table 115. Latin America Angiogenesis Assay Revenue by Type (2019-2024) & (US$ Million)

Table 116. Latin America Angiogenesis Assay Revenue by Application (2019-2024) & (US$ Million)

Table 117. Middle East and Africa Angiogenesis Assay Revenue by Country (2019-2024) & (US$ Million)

Table 118. Middle East and Africa Angiogenesis Assay Revenue by Country (2025-2030) & (US$ Million)

Table 119. Middle East and Africa Angiogenesis Assay Revenue by Type (2019-2024) & (US$ Million)

Table 120. Middle East and Africa Angiogenesis Assay Revenue by Application (2019-2024) & (US$ Million)

Table 121. Angiogenesis Assay Key Raw Materials, Industry Status and Trend

Table 122. Angiogenesis Assay Key Raw Materials and Upstream Suppliers

Table 123. Angiogenesis Assay Clients Status and Trend

Table 124. Angiogenesis Assay Typical Clients

Table 125. Angiogenesis Assay Distributors

Table 126. Angiogenesis Assay Market Trends

Table 127. Angiogenesis Assay Market Drivers

Table 128. Angiogenesis Assay Market Challenges

Table 129. Angiogenesis Assay Market Restraints

Table 130. Research Programs/Design for This Report

Table 131. Key Data Information from Secondary Sources

Table 132. Key Data Information from Primary Sources

List of Figures

Figure 1. Angiogenesis Assay Product Picture

Figure 2. Global Angiogenesis Assay Revenue Market Share by Type in 2023 & 2030

Figure 3. In Vitro Assay Kit Product Picture

Figure 4. In Vivo Assay Kit Product Picture

Figure 5. Global Angiogenesis Assay Revenue Market Share by Application in 2023 & 2030

Figure 6. Academic Institution

Figure 7. Biotech Companies

Figure 8. Angiogenesis Assay Report Years Considered

Figure 9. Global Angiogenesis Assay Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 10. Global Angiogenesis Assay Market Size 2019-2030 (US$ Million)

Figure 11. Global Angiogenesis Assay Market Size Market Share by Region: 2023 Versus 2030

Figure 12. Global Angiogenesis Assay Revenue Market Share by Region (2019-2030)

Figure 13. Angiogenesis Assay Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 14. Global Angiogenesis Assay Revenue Market Share Forecast by Type (2019-2030)

Figure 15. Global Angiogenesis Assay Revenue Market Share Forecast by Application (2019-2030)

Figure 16. North America Angiogenesis Assay Revenue 2019-2030 (US$ Million)

Figure 17. North America Angiogenesis Assay Revenue Market Share by Type (2019-2024)

Figure 18. North America Angiogenesis Assay Revenue Market Share by Application (2019-2024)

Figure 19. Asia-Pacific Angiogenesis Assay Revenue 2019-2030 (US$ Million)

Figure 20. Asia-Pacific Angiogenesis Assay Revenue Market Share by Region (2019-2030)

Figure 21. Asia-Pacific Angiogenesis Assay Revenue Market Share by Type (2019-2024)

Figure 22. Asia-Pacific Angiogenesis Assay Revenue Market Share by Application (2019-2024)

Figure 23. Europe Angiogenesis Assay Revenue Growth Rate 2019-2030 (US$ Million)

Figure 24. Europe Angiogenesis Assay Revenue Market Share by Country (2019-2030)

Figure 25. Europe Angiogenesis Assay Revenue Market Share by Type (2019-2024)

Figure 26. Europe Angiogenesis Assay Revenue Market Share by Application (2019-2024)

Figure 27. Latin America Angiogenesis Assay Revenue Growth Rate 2019-2030 (US$ Million)

Figure 28. Latin America Angiogenesis Assay Revenue Market Share by Country (2019-2024)

Figure 29. Latin America Angiogenesis Assay Revenue Market Share by Type (2019-2024)

Figure 30. Latin America Angiogenesis Assay Revenue Market Share by Application (2019-2024)

Figure 31. Middle East and Africa Angiogenesis Assay Revenue Growth Rate 2019-2030 (US$ Million)

Figure 32. Middle East and Africa Angiogenesis Assay Revenue Market Share by Country (2019-2030)

Figure 33. Middle East and Africa Angiogenesis Assay Revenue Market Share by Type (2019-2024)

Figure 34. Middle East and Africa Angiogenesis Assay Revenue Market Share by Application (2019-2024)

Figure 35. Angiogenesis Assay Supply Chain (Upstream and Downstream Market)

Figure 36. Global Production Market Share of Angiogenesis Assay Raw Materials by Region in 2023

Figure 37. Angiogenesis Assay Distribution Channels

Figure 38. Global Angiogenesis Assay Percentage 2019-2030: Indirect Sales VS Direct Sales

Figure 39. Global Angiogenesis Assay Percentage 2019-2030: Online Sales VS Offline Sales

Figure 40. Bottom-up and Top-down Approaches for This Report

Figure 41. Data Triangulation

Figure 42. Key Executives Interviewed

Figure 43. Global Angiogenesis Assay Percentage 2019-2030: Online Sales VS Offline Sales

Figure 44. Bottom-up and Top-down Approaches for This Report

Figure 45. Data Triangulation

Figure 46. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions